Concepedia

David S. Hewings

DS

Statistics

Publications

12

Citations

749

H-Index

12

Active since

2011

Affiliations

University of Oxford(Current)

Mansfield University

Roche (Switzerland)

Genomics (United Kingdom)

Oxford Research Group

David S. Hewings is an author at University of Oxford specializing in drug discovery, pharmacology, and ligand binding.

ORCID

Publications per year

2011–2023

12

Publications

12

3,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain Ligands

David S. Hewings, Minghua Wang, Martin Philpott et al. · Journal of Medicinal Chemistry · 2011 · 223 citations · Full text

, , +15

Optimization of 3,5-Dimethylisoxazole Derivatives as Potent Bromodomain Ligands

David S. Hewings, O. Fedorov, P. Filippakopoulos et al. · Journal of Medicinal Chemistry · 2013 · 139 citations · Full text

, , +16

Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes

David S. Hewings, Johanna Heideker, P. Taylur et al. · Nature Communications · 2018 · 87 citations · Full text

, , +17

The design and synthesis of 5- and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains

Duncan A. Hay, O. Fedorov, P. Filippakopoulos et al. · MedChemComm · 2012 · 66 citations · Full text

, , +9

Organocatalytic removal of formaldehyde adducts from RNA and DNA bases

Saswata Karmakar, Emily M. Harcourt, David S. Hewings et al. · Nature Chemistry · 2015 · 51 citations · Full text

, , +14

1–5 of 12